li
the british
psychoLogicaL society
promoting excelLence in psychology
ANNUAL REPORT2025
Doc ID.. 8c5b609a3360428e3519d680d25210ce80c03bf

## 



## 

## 












## 

## 




## 




## 

## 




## 


## 



## 

## 




## 

## 

## 

## 

## 



## 



## 





## 


## 


## 

## 



## 

## 

## 




## 


## 



## 

## 




## 

## 

|**Networks**|**Applications**<br>**received**|**Successful**<br>**appointments**|
|---|---|---|
|Branches|33|31|
|Divisions|71|48|
|Sections|79|60|
|Faculties|43|22|
|Special Groups|8|6|
|Divisional Branches|46|36|



## 


## 




## 

## 









## 







## 




## 


## 

## 


## 





## 

## 




## 



## 

## 




## 






## 





## 

## 

## 

## 





## 






## 

## 


## 





## 

## 


## 



## 

## 


## 

## 

## 

## 



## 


## 






## 


## 



## 

## 

## 


## 




## 



## 



## 



## 








## 








## 

## 

## 


## 





## 







## 

## 

|**Qualification**|**Enrolments**|**Completers**|
|---|---|---|
|Qualification in Counselling Psychology|0*|1|
|Qualification in Clinical<br>Neuropsychology|6|6|
|Qualification in Educational Psychology<br>(Scotland) (Stage 2)|24|14|
|Qualification in Forensic Psychology<br>(Stage 2)|28|118|
|Qualification in Health Psychology<br>(Stage 2)|9|12|
|Qualification in Occupational<br>Psychology (Stage 2)|31|35|
|Qualification in Sport & Exercise<br>Psychology (Stage 2)|23|18|











## 

## 

## 

## 

## 

## 



## 



## 


## 




## 


## 

## 



## 



Financial report
2025
t)oc ID.. 81Sb609a3360428e35f9cf680d2521 Oce80e03bf




## 

## 

## 



## 

## 

## 



## 

## 



## 

## 

## 



## 

## 

## 

## 



## 

## 

## 



## 

## 

## 



## 




## 

## 

## 

## 



## 

## 

## 



## 

## 



## 


## 



## 

## 

|||**2025**|**2025**|**2025**|**2025**|**2024**|
|---|---|---|---|---|---|---|
|||**Unrestricted**|**Designated**|**Restricted**|**Total**|**Total**|
|||**Funds**|**Funds**|**Funds**|||
||**Notes**|**£'000**|**£'000**|**£'000**|**£'000**|**£'000**|
|**Income from:**|||||||
|**Charitable activities:**|||||||
|Subscriptions||7,487|-|-|7,487|7,613|
|Registers and directories||514|-|-|514|524|
|Conferences and events||601|-|-|601|683|
|Journals and book publishing|4|1,718|-|-|1,718|1,694|
|Other income|5|2,352|-|-|2,352|2,340|
|**Trading activities**|7|340|-|-|340|492|
|**Investment income**|6|45|-|-|45|44|
|**Total income**||**13,057**|**-**|**-**|**13,057**|**13,390**|
|**Expenditure on:**|||||||
|Trading activities|7|251|-|-|251|324|
|**Charitable activities**||12,476|-|-|12,476|12,295|
|**Other expenditure: **Black and Asian||60|||60||
|Fund|||-|-||45|
|**Total expenditure**||**12,787**|**-**|**-**|**12,787**|**12,664**|
|**Net income/(expenditure) before**||**270**|-|-|**270**|**726**|
|**gains and losses on investments**|||||||
|Net gains/(losses) on investments|13|(267)|-|-|(267)|659|
|**Net income/(expenditure) for the year**||**3**|**-**|**-**|**3**|**1,385**|
|Transfers between funds|18|78|(75)|(3)|-|-|
|**Net movement in funds**||**81**|**(75)**|**(3)**|**3**|**1,385**|
|**Reconciliation of funds:**|||||||
|Total funds brought forward||16,961|135|56|17,152|15,767|
|**Total funds carried forward**||**17,042**|**60**|**53**|**17,155**|**17,152**|





## 

## 

|||**2025**|**2025**|**2025**|**2025**|**2024**|
|---|---|---|---|---|---|---|
|||**Unrestricted**|**Designated**|**Restricted**|**Total**|**Total**|
|||**Funds**|**Funds**|**Funds**|||
||**Notes**|**£'000**|**£'000**|**£'000**|**£'000**|**£'000**|
|**Income from:**|||||||
|**Charitable activities:**|||||||
|Subscriptions||7,487|-|-|7,487|7,613|
|Registers and directories||514|-|-|514|524|
|Conferences and events||601|-|-|601|683|
|Journals and book publishing|4|1,718|-|-|1,718|1,694|
|Other income|5|2,352|-|-|2,352|2,340|
|**Trading activities**|7|88|-|-|88|300|
|**Investment income**|6|45|-|-|45|44|
|**Total income**||**12,805**|**-**|**-**|**12,805**|**13,198**|
|**Expenditure on:**|||||||
|**Charitable activities**||12,475|-|-|12,475|12,295|
|**Other expenditure: **Black and Asian Fund||60|-|-|60|45|
|**Total expenditure**||**12,535**|**-**|**-**|**12,535**|**12,340**|
|**Net income/(expenditure) before**||**270**|-|-|**270**|**858**|
|**gains and losses on investments**|||||||
|Net gains/(losses) on investments|13|(267)|-|-|(267)|659|
|**Net income/(expenditure) for the year**||**3**|**-**|**-**|**3**|**1,517**|
|Transfers between funds|18|78|(75)|(3)|-|-|
|**Net movement in funds**||**81**|**(75)**|**(3)**|**3**|**1,517**|
|**Reconciliation of funds:**|||||||
|Total funds brought forward||16,961|135|56|17,152|15,635|
|**Total funds carried forward**||**17,042**|**60**|**53**|**17,155**|**17,152**|





## 

|||**2025**|**2024**|
|---|---|---|---|
||**Notes**|**£'000**|**£'000**|
|**Fixed Assets**||||
|Tangible assets|12|6,736|6,902|
|Investments|13|11,975|12,241|
|**Total fixed assets**||**18,711**|**19,143**|
|**Current Assets**||||
|Debtors|14|1,973|1,604|
|Cash at bank and in hand||1,264|1,049|
|**Total current assets**||**3,237**|**2,653**|
|**Liabilities**||||
|Creditors: amounts falling due within one year|15|(4,422)|(4,269)|
|**Net current liabilities**||**(1,185)**|**(1,616)**|
|**Total assets less current liabilities**||17,526|17,527|
|Provisions|16|(371)|(375)|
|**Net assets**||**17,155**|**17,152**|
|**The funds of the Group:**|18|||
|Restricted income funds||53|56|
|**Unrestricted funds:**||||
|General funds||13,043|12,962|
|Designated funds||60|135|
|Revaluation reserve||3,999|3,999|
|**Total unrestricted funds**||**17,102**|**17,096**|
|**Total funds**||**17,155**|**17,152**|




## 



|||**2025**|**2024**|
|---|---|---|---|
||**Notes**|**£'000**|**£'000**|
|**Fixed Assets**||||
|Tangible assets|12|6,736|6,902|
|Investments|13|11,975|12,241|
|**Total fixed assets**||**18,711**|**19,143**|
|**Current Assets**||||
|Debtors|14|1,873|1,755|
|Cash at bank and in hand||1,181|863|
|**Total current assets**||**3,054**|**2,618**|
|**Liabilities**||||
|Creditors: amounts falling due within one year|15|(4,239)|(4,234)|
|**Net current liabilities**||**(1,185)**|**(1,616)**|
|**Total assets less current liabilities**||17,526|17,527|
|Provisions|16|(371)|(375)|
|**Net assets**||**17,155**|**17,152**|
|**The funds of the Society:**|18|||
|Restricted income funds||53|56|
|**Unrestricted funds:**||||
|General funds||13,043|12,962|
|Designated funds||60|135|
|Revaluation reserve||3,999|3,999|
|**Total unrestricted funds**||**17,102**|**17,096**|
|**Total funds**||**17,155**|**17,152**|



## 



## 

## 

|||**Group**|**Group**|**Society**|**Society**|
|---|---|---|---|---|---|
|||**2025**|**2024**|**2025**|**2024**|
||**Notes**|**£'000**|**£'000**|**£'000**|**£'000**|
|**Net cash provided by operating activities**|22|**173**|**213**|**276**|**302**|
|**Cash flows from investing activities:**||||||
|Dividends and interest from investments||45|44|45|44|
|Purchase of tangible fixed assets||(3)|(36)|(3)|(36)|
|Disposal of tangible fixed assets||-|-|-|-|
|Proceeds from sale of investments||-|-|-|-|
|**Net cash provided by investing activities**||**42**|**8**|**42**|**8**|
|**Net cash from/(used) in financing activities**||||||
|Repayment of borrowing||-|-|-|-|
|**Net cash provided by (used in) financing activities**||-|-|-|-|
|**Change in cash and cash equivalents in the year**||**215**|**221**|**318**|**310**|
|Cash and cash equivalents at the beginning of the year||1,049|828|863|553|
|**Cash and cash equivalents at the end of the year**||**1,264**|**1,049**|**1,181**|**863**|





## 

## 

## 

## 

## 

## 



## 

## 

## 

## 

## 



## 

## 

## 



## 

## 

## 

## 

## 

## 

## 



## 

## 

## 

## 

## 

## 

||**2025**|**2024**|
|---|---|---|
||**£'000**|**£'000**|
|Income from journal subscriptions and sales|1,688|1,680|
|Income from book and publications sales|30|14|
||**1,718**|**1,694**|





## 

||**2025**|**2024**|
|---|---|---|
||**£'000**|**£'000**|
|Advertising revenue|142|193|
|Examination income|795|786|
|Quality Assurance|1,050|1,018|
|Rental income|33|32|
|Professional Development Centre|316|306|
|Sundry income|16|5|
||**2,352**|**2,340**|



## 

||**2025**|**2024**|
|---|---|---|
||**£'000**|**£'000**|
|Income from listed investments|45|44|
||**45**|**44**|



## 

## 

## 

||**2025**|**2024**|
|---|---|---|
||**£'000**|**£'000**|
|Turnover|210|289|
|Cost of sales|(90)|(98)|
|**Gross Profit**|**120**|**191**|
|Distribution costs|(92)|(106)|
|Administrative costs|(26)|(46)|
|**Profit/(Loss) before taxation**|**2**|**39**|
|Taxation|-|-|
|**Profit/(Loss) for year**|**2**|**39**|





## 

||**2025**|**2024**|
|---|---|---|
||**£'000**|**£'000**|
|**Current assets**|||
|Debtors|71|81|
|Cash at bank|31|42|
|**Total current assets**|**102**|**123**|
|Creditors: amount falling within one year|(102)|(123)|
|**Net assets**|**-**|**-**|



## 



## 

||**2025**|**2024**|
|---|---|---|
||**£'000**|**£'000**|
|Turnover|144|203|
|Cost of sales|(42)|(65)|
|**Gross Profit**|**102**|**138**|
|Administrative costs|(30)|(38)|
|**Profit/(Loss) before taxation**|**72**|**100**|
|Taxation|-|-|
|**Profit/(Loss) for year**|**72**|**100**|



## 

||**2025**|**2024**|
|---|---|---|
||**£'000**|**£'000**|
|**Current assets**|||
|Debtors|30|2|
|Cash at bank|52|144|
|**Total current assets**|**82**|**146**|
|Creditors: amount falling within one year|(82) _|(146)|
|**Net assets**|**-**|**-**|





## 

||**Property**|**IT**|**HR & Finance**|**Directorate**|**2025**|**2024**|
|---|---|---|---|---|---|---|
||**£'000**|**£'000**|**£'000**|**£'000**|**£'000**|**£'000**|
|**Charitable expenditure**|||||||
|Advancement of psychology|78|227|162|58|525|291|
|Application of psychology|5|16|11|4|36|20|
|Conferences and events|13|37|26|9|85|47|
|Co-operation|17|48|35|12|112|62|
|Diffusion of knowledge|126|370|264|94|855|474|
|Examinationsandtraining|63|186|133|47|429|238|
|Membership|147|430|307|110|994|551|
|Science and policy|58|169|120|43|390|216|
|**Total support costs allocated**|**507**|**1,483**|**1,058**|**377**|**3,426**|**1,899**|



## 

|Net income is stated after charging:|**2025**|**2024**|
|---|---|---|
||**£'000**|**£'000**|
|Depreciation|169|214|
|Auditors remuneration|||
|- Audit services|38|42|
|- Other services|9|9|



## 

||**2025**|**2024**|**2025**|**2024**|
|---|---|---|---|---|
||**Full time**|**Full time**|**Part time**|**Part time**|
|Leicester office|91|95|11|13|
|London office|19|16|3|2|
|Remote|7|2|6|5|
||**117**|**113**|**20**|**20**|





||**2025**|**2024**|
|---|---|---|
||**Total**|**Total**|
||**£'000**|**£'000**|
|Gross wages and salaries|5,821|5,785|
|Employer's national insurance|731|628|
|Defined contribution pension costs|892|533|
|Redundancy costs|-|181|
|Payment in lieu of notice|15|99|
||**7,459**|**7,226**|



||**2025**|**2024**|
|---|---|---|
||**Total**|**Total**|
||**£'000**|**£'000**|
|Payment in lieu of notice|15|99|
|Settlement agreement|-|-|
|Redundancy|-|181|
||**15**|**280**|





||**2025**|**2024**|
|---|---|---|
||**Number**|**Number**|
|£60,000-£69,999|3|5|
|£70,000-£79,999|2|2|
|£80,000-£89,999|1|1|
|£90,000-£99,999|1|-|
|£100,000-£109,999|1|1|
|£110,000-£119,999|1|1|
|£120,000-£129,999|-|-|
|£130,000-£139,999|-|-|
|£140,000-£149,999|1|1|
|£150,000-£159,999|-|1|
|£160,000-£169,999|1|-|



## 



||**2025**|**2024**|
|---|---|---|
||**£**|**£**|
|Current President (Dr R Raczka)|||
|Former President (Dr N Hayes)||12,309|
|||**12,309**|



## 

||**Freehold**||||
|---|---|---|---|---|
||**Land**|**Computer**|**Office**||
||**& Buildings**|**& Print**|**equipment**|**Total**|
||**£'000**|**£'000**|**£'000**|**£'000**|
|**Cost**|||||
|At 1 January 2025|9,260|276|428|9,964|
|Additions|-|3|-|3|
|Disposals|-|-|-|-|
|**At 31 December 2025**|**9,260**|**279**|**428**|**9,967**|
|**Depreciation**|||||
|At 1 January 2025|2,465|242|356|3,063|
|Charge for the year|125|18|25|168|
|Disposals|-|-|-|-|
|**At 31 December 2025**|**2,590**|**260**|**381**|**3,231**|
|**Net Book Value**|||||
|**At 31 December 2025**|**6,670**|**19**|**47**|**6,736**|
|**At 31 December 2024**|**6,795**|**34**|**72**|**6,902**|





## 

|**Fixed asset investments**|||
|---|---|---|
||**2025**|**2024**|
||**£'000**|**£'000**|
|**Market value at 1 January 2025**|12,241|11,582|
|Additions|||
|Disposal proceeds|||
|Net investment (loss)/gain - unrealised|(267)|659|
|Net investment (loss)/gain - realised|||
|**Market value at 31 December 2025**|**11,975**|**12,241**|
|Cash awaiting investment|||
|**Total at 31 December 2025**|**11,975**|**12,241**|



|Overseas Equities|63.21%|
|---|---|
|UK Equities|8.56%|
|Infrastructure & Operating Assets|4.68%|
|Cash & Near Cash|2.95%|
|Fixed Interest|10.83%|
|Property|4.44%|
|Contractual, Private Equity & Other|5.32%|
|Derivatives|0.01%|



## 

||**2025**|**2024**|**2025**|**2024**|
|---|---|---|---|---|
||**Group**|**Group**|**Society**|**Society**|
||**£'000**|**£'000**|**£'000**|**£'000**|
|Trade debtors|688|381|449|312|
|Prepayments and accrued income|1,285|1,201|1,285|1,201|
|Amounts due from subsidiary companies|-|-|139|221|
|VAT recoverable|-|22|-|22|
||**1,973**|**1,604**|**1,873**|**1,755**|





## 

||**2025**|**2024**|**2025**|**2024**|
|---|---|---|---|---|
||**Group**|**Group**|**Society**|**Society**|
||**£'000**|**£'000**|**£'000**|**£'000**|
|Trade creditors|393|268|210|255|
|Subscriptions received in advance|1,783|1,627|1,783|1,627|
|Other deferred income|1,516|1,529|1,516|1,500|
|Other creditors|111|134|111|134|
|Accruals|408|535|408|529|
|Amounts due to subsidiary companies|0|-|0|13|
|Other taxation and social security|211|175|211|175|
||**4,422**|**4,269**|**4,239**|**4,234**|



## 

||**2025**|**2025**|
|---|---|---|
||**Group**|**Society**|
||**£'000**|**£'000**|
|**Balance as at 1 January 2025**|3,156|3,127|
|Amounts released from previous year|(2,344)|(2,314)|
|Income deferred in the year|2,487|2,486|
|**Balance as at 31 December 2025**|**3,299**|**3,299**|





## 

||**At 1 Jan 2025**|**Additions**|**Utilised**|**Released**|**At 31 Dec 2025**|
|---|---|---|---|---|---|
||**£'000**||||**£'000**|
|HMRC voluntary disclosure|375|-|-|(4)|371|
|**Total provisions**|**375**|**-**|**-**|**(4)**|**371**|



## 



## 

## 

|||||||**Funds**|
|---|---|---|---|---|---|---|
||**Funds**|||||**carried**|
||**brought**|||||**forward**|
||**forward at**|||**Gains**||**at 31 Dec**|
||**1 Jan 2025**|**Income**|**Expenditure**|**Losses**|**Transfers**|**2025**|
||**£'000**|**£'000**|**£'000**|**£'000**|**£'000**|**£'000**|
|General|12,962|13,057|(12,787)|(267)|78|13,043|
|Designated fund|135||||(75)|60|
|Revaluation reserve|3,999||||-|3,999|
|Restricted fund|56||||(3)|53|
||**17,152**|**13,057**|**(12,787)**|**(267)**|**-**|**17,155**|



## 

|||||||**Funds**|
|---|---|---|---|---|---|---|
||**Funds**|||||**carried**|
||**brought**|||||**forward**|
||**forward at**|||**Gains**||**at 31 Dec**|
||**1 Jan2025**|**Income**|**Expenditure**|**Losses**|**Transfers**|**2025**|
||**£'000**|**£'000**|**£'000**|**£'000**|**£'000**|**£'000**|
|General|12,962|12,805|(12,535)|(267)|78|13,043|
|Designated fund|135||||(75)|60|
|Revaluation reserve|3,999||||-|3,999|
|Restricted fund|56||||(3)|53|
||**17,152**|**12,805**|**(12,535)**|**(267)**|**-**|**17,155**|





## 

|||||||**Funds**|
|---|---|---|---|---|---|---|
||**Funds**|||||**carried**|
||**brought**|||||**forward**|
||**forward at**|||**Gains**||**at 31 Dec**|
||**1 Jan 2024**|**Income**|**Expenditure**|**Losses**|**Transfers**|**2024**|
||**£'000**|**£'000**|**£'000**|**£'000**|**£'000**|**£'000**|
|General|11,520|13,390|(12,664)|659|57|12,962|
|Designated fund|175||||(40)|135|
|Revaluation reserve|4,014||||(15)|3,999|
|Restricted fund|58||||(2)|56|
||**15,767**|**13,390**|**(12,664)**|**659**|**-**|**17,152**|



## 

|||||||**Funds**|
|---|---|---|---|---|---|---|
||**Funds**|||||**carried**|
||**brought**|||||**forward**|
||**forward at**|||**Gains**||**at 31 Dec**|
||**1 Jan 2024**|**Income**|**Expenditure**|**Losses**|**Transfers**|**2024**|
||**£'000**|**£'000**|**£'000**|**£'000**|**£'000**|**£'000**|
|General|11,388|13,198|(12,340)|659|57|12,962|
|Designated fund|175||||(40)|135|
|Revaluation reserve|4,014||||(15)|3,999|
|Restricted fund|58||||(2)|56|
||**15,635**|**13,198**|**(12,340)**|**659**|**-**|**17,152**|





## 

||||||**Funds**|
|---|---|---|---|---|---|
||**Funds**||||**carried**|
||**brought**||||**forward**|
||**forward at**|||**Gains**|**at 31 Dec**|
||**1 Jan 2025**|**Income**|**Expenditure**|**Losses**|**2025**|
||**£'000**|**£'000**|**£'000**|**£'000**|**£'000**|
|William Inman|5|-|(3)|-|2|
|Visual Archive|10||||10|
|BJEP Fund|41||||41|
||**56**|**-**|**(3)**|**-**|**53**|



||||||**Funds**|
|---|---|---|---|---|---|
||**Funds**||||**carried**|
||**brought**||||**forward**|
||**forward at**|||**Gains**|**at 31 Dec**|
||**1 Jan 2024**|**Income**|**Expenditure**|**Losses**|**2024**|
||**£'000**|**£'000**|**£'000**|**£'000**|**£'000**|
|William Inman|7|-|(2)|-|5|
|Visual Archive|10|-|||10|
|BJEP Fund|41|-|||41|
||**58**|**-**|**(2)**|**-**|**56**|





## 

## 

||**Unrestricted**|**Restricted**|**Total**|
|---|---|---|---|
||**£'000**|**£'000**|**£'000**|
|Tangible fixed assets|6,736|0|6,736|
|Investments|11,975|0|11,975|
|Current assets|3,184|53|3,237|
|Current liabilities|(4,793)|0|(4,793)|
|**Total net assets**|**17,102**|**53**|**17,155**|



## 

||**Unrestricted**|**Restricted**|**Total**|
|---|---|---|---|
||**£'000**|**£'000**|**£'000**|
|Tangible fixed assets|6,736|0|6,736|
|Investments|11,975|0|11,975|
|Current assets|3,001|53|3,054|
|Current liabilities|(4,610)|0|(4,610)|
|**Total net assets**|**17,102**|**53**|**17,155**|



## 

||**Unrestricted**|**Restricted**|**Total**|
|---|---|---|---|
||**£'000**|**£'000**|**£'000**|
|Tangible fixed assets|6,902|0|6,902|
|Investments|12,241|0|12,241|
|Current assets|2,597|56|2,653|
|Current liabilities|(4,644)|0|(4,644)|
|**Total net assets**|**17,096**|**56**|**17,152**|





## 

||**Unrestricted**|**Restricted**|**Total**|
|---|---|---|---|
||**£'000**|**£'000**|**£'000**|
|Tangible fixed assets|6,902|0|6,902|
|Investments|12,241|0|12,241|
|Current assets|2,562|56|2,618|
|Current liabilities|(4,609)|0|(4,609)|
|**Total net assets**|**17,096**|**56**|**17,152**|



## 



## 

|**Divisions**|**Income**|**Expenditure**|
|---|---|---|
|Academics, Researchers and Teachers|33,591|26,503|
|Clinical|383,611|274,620|
|Coaching|60,944|53,966|
|Counseling|139,073|94,660|
|Educational and Child|89,612|77,925|
|Forensic|94,661|127,380|
|Health|81,851|84,608|
|Neuropsychology|34,276|39,211|
|Occupational|138,668|131,308|
|Sport and Exercise|37,341|26,104|
|Educational (Scottish)|13,434|10,716|
|**Sections**|||
|Cognitive|9,354|9,592|
|Community|12,364|12,836|
|Consciousness and Experiential|3,532|1,390|
|Crisis, Disaster and Trauma|11,297|9,459|
|Cyberpsychology|19,926|22,304|
|Defence and Security|9,992|9,197|
|Developmental|38,493|24,916|
|Historical, Philosophical and Theoretical|2,156|507|
|Male|3,494|3,879|
|Mathematical, Statistical and Computing|1,174|901|
|Political|1,068|542|
|Psychobiology|4,126|6,172|
|Education|30,754|30,920|
|Sexualities|3,765|976|
|Women and Equalities|17,752|17,201|
|Psychotherapy|13,101|10,880|
|Qualitative Methods|42,107|37,838|
|Social|34,526|14,151|
|Transpersonal|15,474|12,625|
|Environmental|1,771|1,348|





|**Special Groups**|||
|---|---|---|
|Independent Practitioners|11,827|7,824|
|Social Care|4,936|2,875|
|**DCP Faculties**|||
|Addictions|5,329|4,677|
|Children, Young People and Families|25,923|16,972|
|Clinical Health Psychology|5,031|4,552|
|Eating Disorders|4,534|2,819|
|Forensic Clinical Psychology|5,572|2,528|
|HIV & Sexual Health|929|952|
|Holistic Psychology|1,395|761|
|Leadership and Management|17,237|15,357|
|Intellectual Disabilities|25,387|47,090|
|Oncology and Palliative Care|1,729|256|
|Perinatal Psychology|7,755|8,243|
|Psychosis & Complex Mental Health|9,483|6,468|
|Psychology of Older People|41,901|36,242|
|**Total**|**1,552,257**|**1,332,252**|



||**Members**|**£**|
|---|---|---|
|Academics|1|49|
|Clinical|27|107,537|
|Counselling|1|3,750|
|Coaching|1|1,193|
|Educational and Child|3|2,535|
|Health|2|3,852|
|Forensic|1|3,750|
|Psychotherapy Section|2|823|
|Developmental Section|1|100|





## 

||**Group**|**Group**|**Society**|**Society**|
|---|---|---|---|---|
||**2025**|**2024**|**2025**|**2024**|
||**£'000**|**£'000**|**£'000**|**£'000**|
|**Net (outgoing)/incoming resources**|**3**|**1,385**|**3**|**1,517**|
|Adjustments for:|||||
|Depreciation charges|169|214|169|214|
|Loss/(Gains) on investments|267|(659)|267|(659)|
|Investment income in investing activities|(45)|(44)|(45)|(44)|
|(Increase)/Decrease in debtors|(369)|(392)|(118)|(487)|
|(Decrease)/Increase in creditors|148|(291)|-|(239)|
|**Net cash provided by (used in) operating**|**173**|**213**|**276**|**302**|
|**activities**|||||



## 

||**2025**|**2024**|
|---|---|---|
||**£'000**|**£'000**|
|Amounts due:|||
|Within 1 year|2|2|
|Within 2-4 years|3|5|



## 



|**Chief Executive**|Mr S. Bajwa|
|---|---|
|**Deputy Chief**<br>**Executive**|Ms D. Ashby|
|**Director of**||
|**Communications**|Ms R. Dufton|
|**and Engagement**||
|**Acting Director of**||
|**Communications**|Mr J. Warwick (from 01.07.2025)|
|**and Engagement**||
|**Director of Finance**|Mrs P. Bassi|
|**and Resources**||
|**Director of**||
|**Knowledge and**|Ms D. Malpass|
|**Insight**||
|**Director of IT**|Mr T. Colson|









